0001209191-19-014797.txt : 20190228 0001209191-19-014797.hdr.sgml : 20190228 20190228200218 ACCESSION NUMBER: 0001209191-19-014797 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190226 FILED AS OF DATE: 20190228 DATE AS OF CHANGE: 20190228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYANT DOUGLAS C CENTRAL INDEX KEY: 0001406652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 19646221 MAIL ADDRESS: STREET 1: C/O QUIDEL CORPORATION STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-26 0 0000353569 QUIDEL CORP /DE/ QDEL 0001406652 BRYANT DOUGLAS C 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 1 1 0 0 President & CEO Common Stock 2019-02-26 4 M 0 20920 15.28 A 322006 D Common Stock 2019-02-26 4 M 0 10523 12.63 A 332529 D Common Stock 2019-02-26 4 S 0 31443 65.72 D 301086 D Common Stock 2019-02-27 4 M 0 22154 12.63 A 323240 D Common Stock 2019-02-27 4 S 0 22154 65.98 D 301086 D Common Stock 2019-02-28 4 M 0 22153 12.63 A 323239 D Common Stock 2019-02-28 4 S 0 22153 65.62 D 301442 D Non-Qualified Stock Options 15.28 2019-02-26 4 M 0 20920 0.00 D 2020-01-18 Common Stock 20920 0 D Non-Qualified Stock Options 12.63 2019-02-26 4 M 0 10523 0.00 D 2021-03-02 Common Stock 10523 75395 D Non-Qualified Stock Options 12.63 2019-02-27 4 M 0 22154 0.00 D 2021-03-02 Common Stock 22154 53241 D Non-Qualified Stock Options 12.63 2019-02-28 4 M 0 22153 0.00 D 2021-03-02 Common Stock 22153 31088 D The weighted average sale price for these transactions was $65.72 per share, with a range of $65.18 to $67.34. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The weighted average sale price for these transactions was $65.98 per share, with a range of $65.30 to $66.50. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The weighted average sale price for these transactions was $65.62 per share, with a range of $65.00 to $66.39. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The amount of securities beneficially owned prior to this transaction included an additional 356 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. 27,729 shares vested on 01/18/2012; 13,865 shares vested on 01/18/2013; 13,864 shares vested on 01/18/2014. 42,959 shares vested on 03/02/2013; 21,479 shares vested on 03/02/2014; 21,480 shares vested on 03/02/2015. All transactions reported herein were effected pursuant to a pre-established 10b5-1 trading plan. Robert J. Bujarski, attorney-in-fact for Douglas C. Bryant 2018-02-28